1Robles LI, Barrios M, Del Pozo E, et al. Effects of K^+ channel bolckers and opener on antinociception induced by agonists of 5 -HT1A receptors[ J]. Eur J Pharmacol, 1996,295 (2 - 3 ) : 181-188.
2Matsubara K. Fhimizu K, Suno M, et al. Tando spirone, a 5 - HT1A agonist,ameliorates movement disorder via non -dopaminergic systems in rats with unilateral 6 - hydroxydopamine - generated lesions [J]. Brain Res,2006,1112( 1 ) :126 - 133.
4Komoto S. Miura S. Antagonists of the type 3 serotonin receptor( 5 - HT3 )in IBS[J]. Nippon Rinsho,2006,64(8) :1487 - 1490.
5Coleski R, Owyang C, Hasler WL. Modulation of intestinal gas dynamics in healthy human volunteers by the 5 - Htreceptor agonist tegaserod[J]. Am J Gastroentrol,2006,101 (8) :1858 -1865.
6Westenberg HG, Liebowitz MR. Overview of panic and social anxiety disorders[J]. J Clin Psychiatry,2004,65 ( Suppl 14 ) :22-26.
7Hibbeln JR, Ferguson TA, Blasbalg TL, et al. Omega -3 fatty acid deficiencies in neurodevetopment, aggression and autonomic dysregulation: opportunities for intervention [ J ]. Int Rev Psychiatry, 2006, 18 (2):107 -118.
8Moshe SL. Mechanisms of action of anticonvulsant agents[ J]. Neurology,2000,55 ( Suppl 1 ) :32 - 40.
9Richelsorr E. Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance[ J]. J Ciin Psychiatry,2003,64(Suppl 13) :5 -12.
